BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17586048)

  • 1. Antimicrobial properties of highly fluorinated tris(pyrazolyl)borates.
    van Waasbergen LG; Fajdetic I; Fianchini M; Rasika Dias HV
    J Inorg Biochem; 2007 Aug; 101(8):1180-3. PubMed ID: 17586048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial properties of highly fluorinated silver(I) tris(pyrazolyl)borates.
    Dias HV; Batdorf KH; Fianchini M; Diyabalanage HV; Carnahan S; Mulcahy R; Rabiee A; Nelson K; van Waasbergen LG
    J Inorg Biochem; 2006 Jan; 100(1):158-60. PubMed ID: 16321442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silver(I) complexes of tris(pyrazolyl)borate ligands bearing six trifluoromethyl and three additional electron-withdrawing substituents.
    Jayaratna NB; Pardue DB; Ray S; Yousufuddin M; Thakur KG; Cundari TR; Dias HV
    Dalton Trans; 2013 Nov; 42(43):15399-410. PubMed ID: 24013162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses of aluminum and zinc alkyl complexes of a highly fluorinated tris(pyrazolyl)borate using [HB(3,5-(CF3)2Pz)3]Ag(THF) as the ligand transfer agent.
    Dias HV; Jin W
    Inorg Chem; 2003 Aug; 42(17):5034-6. PubMed ID: 12924870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silver(I) and copper(I) adducts of a tris(pyrazolyl)borate decorated with nine trifluoromethyl groups.
    Jayaratna NB; Gerus II; Mironets RV; Mykhailiuk PK; Yousufuddin M; Dias HV
    Inorg Chem; 2013 Feb; 52(4):1691-3. PubMed ID: 23368672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.
    Jain J; Arora S; Rajwade JM; Omray P; Khandelwal S; Paknikar KM
    Mol Pharm; 2009; 6(5):1388-401. PubMed ID: 19473014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silver(I) carbonyl and silver(I) ethylene complexes of a B-protected fluorinated tris(pyrazolyl)borate ligand.
    Dias HV; Wang X
    Dalton Trans; 2005 Sep; (18):2985-7. PubMed ID: 16127491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyfluorinated Tris(pyrazolyl)borates. Syntheses and Spectroscopic and Structural Characterization of Group 1 and Group 11 Metal Complexes of [HB(3,5-(CF(3))(2)Pz)(3)](-) and [HB(3-(CF(3))Pz)(3)](-).
    Dias HV; Jin W; Kim HJ; Lu HL
    Inorg Chem; 1996 Apr; 35(8):2317-2328. PubMed ID: 11666431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The silver(I) complex [HB{3-(CF
    Dias HV; Kulkarni N
    Acta Crystallogr C Struct Chem; 2016 Nov; 72(Pt 11):853-856. PubMed ID: 27811425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mononuclear and binuclear sandwich copper(II) complexes with poly(pyrazolyl)borate ligands: syntheses, structures and properties.
    Xing YH; Zhang XJ; Sun Z; Han J; Zhang YH; Zhang BL; Ge MF; Niu SY
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Dec; 68(5):1256-62. PubMed ID: 17368085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonyl and olefin adducts of coinage metals supported by poly(pyrazolyl)borate and poly(pyrazolyl)alkane ligands and silver mediated atom transfer reactions.
    Dias HV; Lovely CJ
    Chem Rev; 2008 Aug; 108(8):3223-38. PubMed ID: 18698738
    [No Abstract]   [Full Text] [Related]  

  • 12. Regioselective synthetic approaches towards 1,2,8,9-tetraazadispiro[4.1.4.2]trideca-2,9-dien-6-ones of potential antimicrobial properties.
    Girgis AS; Barsoum FF; Samir A
    Eur J Med Chem; 2009 Jun; 44(6):2447-51. PubMed ID: 19211175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antimicrobial properties of novel silver/polyrhodanine nanofibers.
    Kong H; Jang J
    Biomacromolecules; 2008 Oct; 9(10):2677-81. PubMed ID: 18771314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supramolecular networks of silver(I) and iron(II) complexes of the third generation tris(pyrazolyl)methane ligand Ph(2)(O)POCH(2)C(pz)(3) (pz = pyrazolyl ring).
    Reger DL; Semeniuc RF; Smith MD
    Dalton Trans; 2008 May; (17):2253-60. PubMed ID: 18414749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tris(pyrazolyl)borato ligand substituents on dioxygen activation and stabilization by copper compounds.
    Aullón G; Gorun SM; Alvarez S
    Inorg Chem; 2006 May; 45(9):3594-601. PubMed ID: 16634590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver(I) complexes of fixed, polytopic bis(pyrazolyl)methane ligands: influence of ligand geometry on the formation of discrete metallacycles and coordination polymers.
    Reger DL; Watson RP; Smith MD
    Inorg Chem; 2006 Dec; 45(25):10077-87. PubMed ID: 17140213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria.
    Raad I; Reitzel R; Jiang Y; Chemaly RF; Dvorak T; Hachem R
    J Antimicrob Chemother; 2008 Oct; 62(4):746-50. PubMed ID: 18653489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antimicrobial activity of selected plant extracts by rapid XTT colorimetry and bacterial enumeration.
    Al-Bakri AG; Afifi FU
    J Microbiol Methods; 2007 Jan; 68(1):19-25. PubMed ID: 16831479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convenient synthesis and antimicrobial evaluation of some novel 2-substituted-3-methylbenzofuran derivatives.
    Abdel-Aziz HA; Mekawey AA; Dawood KM
    Eur J Med Chem; 2009 Sep; 44(9):3637-44. PubMed ID: 19321238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial potential of a lipopeptide biosurfactant derived from a marine Bacillus circulans.
    Das P; Mukherjee S; Sen R
    J Appl Microbiol; 2008 Jun; 104(6):1675-84. PubMed ID: 18194244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.